The LiFFT Study
Contact
Description
Eligibility and criteria
IRB Number:
23-020814
Eligible age range:
Clinical trial phase:
Phase I
Phase II
Official title:
What to expect
- Receive lurbinectedin (study drug) infusions
- Complete frequent clinic visits at CHOP Philadelphia
- Have frequent blood tests, including research blood tests to measure lurbinectedin levelsÂ
- Have periodic imaging performed to evaluate your response to treatment
- Have research tumor biopsies with anesthetic agent or general anesthesia (required if you are 18 years or older and your tumor is accessible (optional if you are under 18)
- Have research genetic tests (if not previously done clinically)
- Get optional research PET scans with a radioactive tracer
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.